Featured
December 1, 2025
Researchers have reached a major milestone in the effort to understand and treat Parkinson’s disease: more than 100,000 DNA samples from study participants around the world have now been genotyped and sequenced through the Global Parkinson’s Genetics Program (GP2).
Read More
Researchers have reached a major milestone in the effort to understand and treat Parkinson’s disease: more than 100,000 DNA samples from study participants around the world have now been genotyped and sequenced through the Global Parkinson’s Genetics Program (GP2).
Read More
GP2 announced its 11th data release at the end of 2025, bringing the total to over 100,000 samples from individuals worldwide, making it one of the most comprehensive and globally representative PD datasets to date.
Read More
In this second edition of the ASAP Research Round-Up, ASAP shares advancements in Q2 2025 across the ASAP portfolio that fill critical knowledge gaps, promote rapid dissemination of scientific insights, expand resource accessibility, and support the next generation of Parkinson’s researchers.
Read More
This news story reports on a new, advanced imaging method that allowed CRN Team Wood to see and study the tiny, toxic alpha-synuclein oligomers (protein clumps) in the brain, creating a new opportunity for earlier diagnosis and better drug treatments.
View Story
ASAP’s Sonya Dumanis, PhD, and Andrew Singleton, PhD, joined The Genetics Podcast to discuss their recent publication in the American Journal of Human Genetics. In the episode, they emphasize the importance of increasing genetic diversity in Parkinson’s disease research and highlight GP2’s role in creating a scalable roadmap for building global research collaborations that can be adapted to other diseases and regions.
View Story
In this second edition of the ASAP Research Round-Up, ASAP shares advancements in Q2 2025 across the ASAP portfolio that fill critical knowledge gaps, promote rapid dissemination of scientific insights, expand resource accessibility, and support the next generation of Parkinson’s researchers.
Read More
Inside Precision Medicine reports on the new ASAP, Allen Institute, and Michael J. Fox Foundation's partnership to unite Collaborative Research Network (CRN) Cloud data from 3 million human cells across 9 brain regions from individuals with Parkinson’s into the Allen Brain Cell (ABC) Atlas visualization tool, which already contains 6.4 million human cells.
View Story
ASAP and Allen Institute announce a new collaboration that creates a common language for visualizing data from Parkinson’s and Alzheimer’s research
Read More
In this blog, ASAP and Allen Institute answer questions about our new collaboration that helps researchers unlock insights into Parkinson’s and other neurodegenerative diseases.
Read More
